3-hydroxybenzylhydrazine has been researched along with Parkinsonian Disorders in 1 studies
3-hydroxybenzylhydrazine: decarboxylase inhibitor; RN given refers to parent cpd; structure
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergstrom, BP | 1 |
| Sanberg, SG | 1 |
| Andersson, M | 1 |
| Mithyantha, J | 1 |
| Carroll, FI | 1 |
| Garris, PA | 1 |
1 other study available for 3-hydroxybenzylhydrazine and Parkinsonian Disorders
| Article | Year |
|---|---|
Functional reorganization of the presynaptic dopaminergic terminal in parkinsonism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Analysis of Variance; Animals; Chromatography, Hi | 2011 |